NCT02558413View on ClinicalTrials.gov

Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
PharmacokineticsHealthy Volunteers
Interventions
DRUG

BTA-C585 oral capsules

BTA-C585; Single ascending doses from 50 mg to 800 mg

DRUG

BTA-C585 matching placebo

Single ascending doses to match 50 to 800 mg BTA-C585 capsules

Trial Locations (1)

78209

Biota Investigational Site, San Antonio

Sponsors
All Listed Sponsors
lead

Biota Pharmaceuticals, Inc.

INDUSTRY